Page 13 - Research Models News Today

Fortune Financial Advisors LLC bought a new position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) in the 2nd quarter, HoldingsChannel reports. The fund bought 4,146 shares of the medical research company’s stock, valued at approximately $872,000. A number of other institutional investors and hedge funds also recently made changes to […]

Legacy Wealth Asset Management LLC grew its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 6.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,358 shares of the medical research company’s stock after […]

Gulf International Bank UK Ltd cut its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 23.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,136 shares of the medical research company’s stock after selling 1,532 shares during the quarter. […]

Choate Investment Advisors cut its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 34.7% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 5,109 shares of the medical research company’s stock after selling 2,711 shares during the quarter. Choate […]

Lindbrook Capital LLC lifted its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 97.0% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 132 shares of the medical research company’s stock after buying an additional 65 shares during the […]

Lindbrook Capital LLC boosted its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 97.0% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 132 shares of the medical research company’s stock after buying an additional 65 shares during the period. Lindbrook Capital LLC’s holdings in Charles River Laboratories International were worth […]

Curi Wealth Management LLC cut its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.9% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 51,308 shares of the medical research company’s stock after selling 3,190 shares during the quarter. Charles River Laboratories International accounts for 1.5% of Curi Wealth […]

Baillie Gifford & Co. lessened its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 0.5% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 85,096 shares of the medical research company’s stock after selling 394 shares during the […]

Charles River Laboratories International (NYSE:CRL – Free Report) had its price objective cut by Evercore ISI from $235.00 to $225.00 in a report issued on Wednesday, FlyOnTheWall reports. Other equities analysts also recently issued reports about the stock. Guggenheim lowered their price objective on shares of Charles River Laboratories International from $255.00 to $225.00 and […]

Mountain Pacific Investment Advisers Inc. ID lifted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 13.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 124,360 shares of the medical research company’s stock […]